Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v4-EN
Language French English
Date Updated 2021-12-07 2021-10-19
Drug Identification Number 02296438 02296438
Brand name SANDOZ OMEPRAZOLE SANDOZ OMEPRAZOLE
Common or Proper name OMEPRAZOLE OMEPRAZOLE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients OMEPRAZOLE OMEPRAZOLE
Strength(s) 10MG 10MG
Dosage form(s) CAPSULE (DELAYED RELEASE) CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30GRC BO 30GRC BO
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2021-09-20 2021-09-20
Estimated end date 2021-12-03 2021-11-19
Actual end date 2021-12-06
Shortage status Resolved Actual shortage
Company comments
Health Canada comments